Dear Reader,
A huge change is coming to our money — thanks in large part to one of the top tech firms in America.
And it could forever alter how you spend… save… and invest — practically overnight.
Frankly, I'm shocked the media hasn't picked up on this yet…
But you can get all the details you need to prepare for this massive change — as well as profit from it — by learning the full story here.
Sincerely,
Jeff Brown
Editor, The Near Future Report
Today’s Market Snapshot U.S. stocks drifted yesterday as bullish AI chatter clashed with mixed signals from cyclical earnings, leaving major indexes pinned near the flatline.
Introduction Cybin Inc., doing business as Helus Pharma, is a clinical-stage biopharmaceutical company focused on novel psychedelic-based therapeutics for mental health (www.otcmarkets.com). In January 2026
Opening Recap Market Pulse: Equities drifted higher yesterday despite the Fed’s tame commentary, with tech wobbling on Tesla’s earnings jitters while broader sectors held firm.
